
Agios Pharm (AGIO)
US$ 35.224.36%
Price Chart
Key Statistics
Market Cap
$ 2.27B
P/E Ratio
3.40
Revenue (TTM)
$ 37.04M
Volume
1.01M
52W High
$ 62.58
52W Low
$ 23.41
Dividend Yield
0.00%
Beta
0.73
Technicals
50-Day MA
32.6882
200-Day MA
37.221
52 Week High
62.58
52 Week Low
23.415
About AGIO
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
Employees
486
Headquarters
Cambridge, MA
CEO
Mr. Brian M. Goff M.B.A.
Latest News
Insider Sale: Chief Medical Officer of $AGIO Sells 11,067 Shares - Quiver Quantitative
4 days ago • Google News
Agios Pharmaceuticals (AGIO) Moves 7.7% Higher: Will This Strength Last? - Yahoo Finance
5 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg